James E. Levine - Net Worth and Insider Trading
James E. Levine Net Worth
The estimated net worth of James E. Levine is at least $429,746 dollars as of 2024-12-28. James E. Levine is the CFO of Cardiff Oncology Inc and owns about 67,716 shares of Cardiff Oncology Inc (CRDF) stock worth over $292,533. James E. Levine is also the CFO of Cidara Therapeutics Inc and owns about 5,792 shares of Cidara Therapeutics Inc (CDTX) stock worth over $137,212. Details can be seen in James E. Levine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James E. Levine has not made any transactions after 2024-12-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James E. Levine
James E. Levine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James E. Levine owns 2 companies in total, including Cidara Therapeutics Inc (CDTX) , and Cardiff Oncology Inc (CRDF) .
Click here to see the complete history of James E. Levine’s form 4 insider trades.
Insider Ownership Summary of James E. Levine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2020-11-10 | Chief Financial Officer |
| CRDF | Cardiff Oncology Inc | 2022-09-16 | Chief Financial Officer |
James E. Levine Latest Holdings Summary
James E. Levine currently owns a total of 2 stocks. Among these stocks, James E. Levine owns 67,716 shares of Cardiff Oncology Inc (CRDF) as of December 18, 2024, with a value of $292,533 and a weighting of 68.07%. James E. Levine also owns 5,792 shares of Cidara Therapeutics Inc (CDTX) as of November 10, 2020, with a value of $137,212 and a weighting of 31.93%.
Latest Holdings of James E. Levine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2024-12-18 | 67,716 | 4.32 | 292,533 |
| CDTX | Cidara Therapeutics Inc | 2020-11-10 | 5,792 | 23.69 | 137,212 |
Holding Weightings of James E. Levine
James E. Levine Form 4 Trading Tracker
According to the SEC Form 4 filings, James E. Levine has made a total of 3 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 7,716 shares on December 18, 2024, which cost James E. Levine around $36,728.
According to the SEC Form 4 filings, James E. Levine has made a total of 1 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cidara Therapeutics Inc is the acquisition of 2,500 shares on November 10, 2020, which cost James E. Levine around $100,500.
Insider Trading History of James E. Levine
- 1
James E. Levine Trading Performance
GuruFocus tracks the stock performance after each of James E. Levine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James E. Levine is 15.88%. GuruFocus also compares James E. Levine's trading performance to market benchmark return within the same time period. The performance of stocks bought by James E. Levine within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James E. Levine's insider trading performs compared to the benchmark.
Performance of James E. Levine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.53 | | | | | |
| Relative Return to S&P 500(%) | 2.05 | | | | | |
James E. Levine Ownership Network
James E. Levine Owned Company Details
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
James E. Levine is the Chief Financial Officer of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and director & President & CEO Jeffrey Stein .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, James E. Levine made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 30,407 shares made by Leslie Tari , a net sale of 40,379 shares made by Taylor Sandison , and a net purchase of 58,000 shares made by Jeffrey Stein .
In summary, during the past 3 months, insiders sold 0 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,751 shares of Cidara Therapeutics Inc (CDTX) were sold and 11,000 shares were bought by its insiders, resulting in a net purchase of 3,249 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
James E. Levine Mailing Address
Above is the net worth, insider trading, and ownership report for James E. Levine. You might contact James E. Levine via mailing address: 55 Cambridge Parkway, 8th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
